BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 28303751)

  • 1. Vasoactive peptides associate with treatment outcome ofbevacizumab-containing therapy in metastatic colorectal cancer.
    Hagman H; Bendahl PO; Melander O; Sundberg J; Johnsson A; Belting M
    Acta Oncol; 2017 May; 56(5):653-660. PubMed ID: 28303751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasoactive peptides with angiogenesis-regulating activity predict cancer risk in males.
    Belting M; Almgren P; Manjer J; Hedblad B; Struck J; Wang TJ; Bergmann A; Melander O
    Cancer Epidemiol Biomarkers Prev; 2012 Mar; 21(3):513-22. PubMed ID: 22267286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-Term Influence of Radiofrequency Ablation on NT-proBNP, MR-proANP, Copeptin, and MR-proADM in Patients With Atrial Fibrillation: Data From the Observational SMURF Study.
    Charitakis E; Walfridsson H; Alehagen U
    J Am Heart Assoc; 2016 Sep; 5(9):. PubMed ID: 27633393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple endothelial biomarkers and noninvasive vascular function in the general population: the Gutenberg Health Study.
    Schnabel RB; Wild PS; Schulz A; Zeller T; Sinning CR; Wilde S; Kunde J; Lubos E; Lackner KJ; Warnholtz A; Gori T; Blankenberg S; Munzel T;
    Hypertension; 2012 Aug; 60(2):288-95. PubMed ID: 22689741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of cardiac stress biomarkers with incident type 2 diabetes and changes in glucose metabolism: KORA F4/FF4 study.
    Sujana C; Seissler J; Jordan J; Rathmann W; Koenig W; Roden M; Mansmann U; Herder C; Peters A; Thorand B; Then C
    Cardiovasc Diabetol; 2020 Oct; 19(1):178. PubMed ID: 33066780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular biomarkers in patients with cancer and their association with all-cause mortality.
    Pavo N; Raderer M; Hülsmann M; Neuhold S; Adlbrecht C; Strunk G; Goliasch G; Gisslinger H; Steger GG; Hejna M; Köstler W; Zöchbauer-Müller S; Marosi C; Kornek G; Auerbach L; Schneider S; Parschalk B; Scheithauer W; Pirker R; Drach J; Zielinski C; Pacher R
    Heart; 2015 Dec; 101(23):1874-80. PubMed ID: 26416836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atrial natriuretic peptide, copeptin and adrenomedullin levels in polycystic ovary syndrome: a case-control study.
    Frøssing S; Nylander M; Aziz M; Skouby SO; Kistorp C; Faber J
    Gynecol Endocrinol; 2017 Jan; 33(1):30-33. PubMed ID: 27424881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple biomarker strategy for improved diagnosis of acute heart failure in older patients presenting to the emergency department.
    Bahrmann P; Bahrmann A; Hofner B; Christ M; Achenbach S; Sieber CC; Bertsch T
    Eur Heart J Acute Cardiovasc Care; 2015 Apr; 4(2):137-47. PubMed ID: 25002708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative evaluation of B-type natriuretic peptide, mid-regional pro-A-type natriuretic peptide, mid-regional pro-adrenomedullin, and Copeptin to predict 1-year mortality in patients with acute destabilized heart failure.
    Gegenhuber A; Struck J; Dieplinger B; Poelz W; Pacher R; Morgenthaler NG; Bergmann A; Haltmayer M; Mueller T
    J Card Fail; 2007 Feb; 13(1):42-9. PubMed ID: 17339002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular Mortality in Chest Pain Patients: Comparison of Natriuretic Peptides With Novel Biomarkers of Cardiovascular Stress.
    Sinning C; Ojeda F; Zeller T; Zengin E; Rupprecht HJ; Lackner KJ; Bickel C; Blankenberg S; Schnabel RB; Westermann D
    Can J Cardiol; 2016 Dec; 32(12):1470-1477. PubMed ID: 27568502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic performance of multiple biomarkers in patients with non-ST-segment elevation acute coronary syndrome: analysis from the MERLIN-TIMI 36 trial (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndromes-Thrombolysis In Myocardial Infarction 36).
    O'Malley RG; Bonaca MP; Scirica BM; Murphy SA; Jarolim P; Sabatine MS; Braunwald E; Morrow DA
    J Am Coll Cardiol; 2014 Apr; 63(16):1644-53. PubMed ID: 24530676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stable precursor fragments of vasoactive peptides in umbilical cord blood of term and preterm infants.
    Koch L; Dabek MT; Frommhold D; Poeschl J
    Horm Res Paediatr; 2011; 76(4):234-9. PubMed ID: 21893934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular biomarkers in preeclampsia at triage.
    Wellmann S; Benzing J; Fleischlin S; Morgenthaler N; Fouzas S; Bührer CA; Szinnai G; Burkhardt T; Lapaire O
    Fetal Diagn Ther; 2014; 36(3):202-7. PubMed ID: 24853905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Copeptin, B-type natriuretic peptide and cystatin C are associated with incident symptomatic PAD.
    Fatemi S; Acosta S; Gottsäter A; Melander O; Engström G; Dakhel A; Zarrouk M
    Biomarkers; 2019 Sep; 24(6):615-621. PubMed ID: 31215249
    [No Abstract]   [Full Text] [Related]  

  • 15. MR-proADM Predicts Exercise Capacity and Survival Superior to Other Biomarkers in PH.
    Kolditz M; Seyfarth HJ; Wilkens H; Ewert R; Bollmann T; Dinter C; Hertel S; Klose H; Opitz C; Grünig E; Höffken G; Halank M
    Lung; 2015 Dec; 193(6):901-10. PubMed ID: 26363916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive value of midregional pro-adrenomedullin compared to natriuretic peptides for incident cardiovascular disease and heart failure in the population-based FINRISK 1997 cohort.
    Funke-Kaiser A; Havulinna AS; Zeller T; Appelbaum S; Jousilahti P; Vartiainen E; Blankenberg S; Sydow K; Salomaa V
    Ann Med; 2014 May; 46(3):155-62. PubMed ID: 24506434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copeptin, pro-atrial natriuretic peptide and pro-adrenomedullin as markers of hypoxic stress in patients with obstructive sleep apnea-a prospective intervention study.
    Karakioulaki M; Grendelmeier P; Strobel W; Schmid T; Jahn K; Grize L; Tamm M; Stolz D
    Respir Res; 2021 Apr; 22(1):114. PubMed ID: 33879148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma concentrations of the vasoactive peptide fragments mid-regional pro-adrenomedullin, C-terminal pro-endothelin 1 and copeptin in hemodialysis patients: associated factors and prediction of mortality.
    Artunc F; Nowak A; Mueller C; Breidthardt T; Twerenbold R; Wagner R; Peter A; Haering HU; Ebmeyer S; Friedrich B
    PLoS One; 2014; 9(1):e86148. PubMed ID: 24465926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered relation of the renin-aldosterone system and vasoactive peptides in type 2 diabetes: The KORA F4 study.
    Then C; Rottenkolber M; Lechner A; Meisinger C; Heier M; Koenig W; Peters A; Rathmann W; Bidlingmaier M; Reincke M; Seissler J
    Atherosclerosis; 2016 Sep; 252():88-96. PubMed ID: 27508320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MR-proANP and MR-proADM for risk stratification of patients with acute chest pain.
    Tzikas S; Keller T; Ojeda FM; Zeller T; Wild PS; Lubos E; Kunde J; Baldus S; Bickel C; Lackner KJ; Münzel TF; Blankenberg S
    Heart; 2013 Mar; 99(6):388-95. PubMed ID: 23213173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.